Study title:
| Type of medicine: Non-centrally authorised vaccines | |||||
| Therapeutic area: Bacterial Infections and Mycoses [C01] AND Virus Diseases [C02] | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: Adsorbed Diphtheria toxoid, adsorbed Tetanus toxoid, adsorbed Pertussis antigens (Pertussis toxoid, Filamentous Haemagglutinin, Pertactin), adsorbed Inactivated poliovirus (type 1, type 2, type 3) | |||||
| ATC code: J07CA02 | |||||
| Document link: | |||||
| Document date: | |||||
| Study number: 102038/ETR | |||||
| EudraCT number: | |||||
| Scope of study: CLINICAL | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | - | - | |